Remscheid, Germany

Julian Egger

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: **Julian Egger: Innovator in Pharmaceutical Chemistry**

Introduction

Julian Egger is a renowned inventor based in Remscheid, Germany, with a focus on pharmaceutical innovations. He holds four patents, showcasing his contributions to the field of medicinal chemistry. His work primarily revolves around developing processes and compounds aimed at treating significant health conditions, particularly cardiopulmonary disorders.

Latest Patents

Among Julian's notable patents is a groundbreaking process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid. This invention emphasizes innovative methods of crystallization, leading to the production of novel crystalline forms beneficial for medical applications. The compound is aimed at being an effective treatment for various pulmonary and cardiovascular diseases, marking a significant step in pharmaceutical advancements.

Career Highlights

Julian's professional journey includes key positions at notable companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His work within these organizations has been pivotal in advancing product development and research in the pharmaceutical sector. The experience gained there has undoubtedly contributed to his prolific patent portfolio.

Collaborations

Throughout his career, Julian has collaborated with esteemed colleagues, including Britta Olenik and Birgit Keil. This teamwork underscores the importance of collaboration in driving innovation and developing new therapeutic strategies in healthcare.

Conclusion

Julian Egger’s contributions to pharmaceutical chemistry are marked by his innovative spirit and dedication to improving healthcare outcomes. His patented processes and compounds represent significant advancements that have the potential to positively impact the treatment of cardiopulmonary ailments. As an inventor, Julian remains a vital part of the ongoing evolution in medical research and pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…